Snapshot from Jul 19, 2026 at 14:14 UTC. For live data and tracking: View Live
Events / Regulatory / STARMED Receives FDA Clearance
Regulatory regulatory approval

STARMED Receives FDA Clearance

Analysis based on 6 articles · First reported Jun 30, 2026 · Last updated Jul 01, 2026

Sentiment
70
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The FDA clearance for STARMED America's thyroid nodule ablation system is expected to positively impact the medical device market by introducing a new, minimally invasive treatment option. This could lead to increased adoption of radiofrequency ablation procedures for thyroid nodules, benefiting STARMED America and potentially other companies in the medical device sector.

Medical Devices Healthcare
Event Summary

STARMED America, a medical device company, has obtained 510(k) clearance from the United States — Food and Drug Administration for a thyroid-specific indication for its ultrasound-guided percutaneous ablation system. This makes STARMED America the first and only company globally with such a specific FDA clearance for thyroid nodule ablation. The clearance, effective May 26, 2026, allows the use of STARMED America's STAR RF Electrode and Viva RF Electrode for eligible, cytologically confirmed benign thyroid nodules in adults. This milestone is significant for physicians and healthcare institutions, providing clear regulatory alignment and a minimally invasive alternative to surgery for patients in the United States.

Key Actions
100 United States — Food and Drug Administration granted clearance STARMED America
50 STARMED America developed electrode
40 Jung Hwan Baek performed procedure
Entities Involved
priv
STARMED America
STARMED America received FDA 510(k) clearance for its thyroid nodule ablation system, making it the first and only company globally with such a specific indication. This significantly enhances its market position and potential for growth in the United States and other countries.
Importance 100.0 Sentiment 80.0
govactor
United States — Food and Drug Administration
The United States — Food and Drug Administration granted 510(k) clearance to STARMED America for its thyroid-specific indication, enabling the company to market its devices for this application in the United States.
Importance 90.0 Sentiment 0.0
oth
STAR RF Electrode
The STAR RF Electrode is one of the devices covered by the FDA clearance, allowing its use for ultrasound-guided percutaneous ablation of benign thyroid nodules.
Importance 60.0 Sentiment 70.0
oth
Viva RF Electrode
The Viva RF Electrode, a monopolar electrode with an adjustable active tip, is also covered by the FDA clearance, expanding the treatment options available.
Importance 60.0 Sentiment 70.0
cnt
United States
The United States market is significantly impacted by this FDA clearance, as it introduces a new, minimally invasive treatment option for thyroid nodules for its population.
Importance 60.0 Sentiment 0.0
per
Henry Shin
Henry Shin, CEO of STARMED America, commented on the significance of the FDA clearance, highlighting the company's long-standing commitment to thyroid-focused technology development.
Importance 50.0 Sentiment 0.0
per
Jung Hwan Baek
Dr. Jung Hwan Baek performed the world's first thyroid RFA procedure using STARMED America equipment, marking a historical point in the development of this technology.
Importance 20.0 Sentiment 0.0
Relationships
United States — Food and Drug Administration related ↔ United States
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.